Dr. Dyrda participates in an international study of central serous chorioretinopathy

Dr. Agnieszka Dyrda, member of the ICR’s Department of Retina and Vitreous and Department of Cataract, has published together with the European Society of Retina and Vitreous (EVRS) an article that evaluates at international level the different therapeutic approaches of this pathology and makes a review of the current literature on it.

The article, published in the prestigious medical journal Acta Ophthalmologica, presents the results of an international study that compares the daily clinical practice of 63 European centers and evaluates the characteristics of 1719 patients diagnosed with central serous chorioretinopathy.

What is central serous chorioretinopathy?

• Central Serous Chorioretinopathy (CSC) is a disease of inflammatory origin that affects the choroid and the retina. Inflammation produces an increase in the permeability of the vessels, thus causing fluid to escape, which accumulates in the choroid and is retained in the barrier of the pygmentary epithelium. However, over time this barrier becomes ineffective and the fluid passes under the retina, eventually causing it to detach.
  
• When the affected area of the retina is the central zone or macula, the patient may perceive diminished and blurred vision, as well as a static central dark spot (black or gray). This prevents or hinders reading and generates a distortion of lines and objects, which may seem smaller than they really are.

• CSC is divided en two types: acute, which usually resolves spontaneously in 80-90% of cases; and chronic, which lasts more than 3 months. Although Central Serosal Chorioretinopathy is not a very common disease, in chronic cases it can endanger vision.

• CSC affects mostly young men (46 years old according to the study) and older women (54 years old in the sample studied).

What does the article say?

This new study has gathered the best experts from 24 European countries, including Dr. Dyrda, to study the characteristics of this disease in the European population and the different therapeutic approaches used in these countries, such as the differences and similarities in the treatment of Central Serous Corioretinopathy.

The article is titled An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of the literature. The European Vitreoretinal Society central serous chorioretinopathy study and can be consulted on the website of Acta Ophthalmologica.